Evidence map›Paper›PMID 32678061›Full record

ArticlePreventing chronic disease2020

Men and COVID-19: A Biopsychosocial Approach to Understanding Sex Differences in Mortality and Recommendations for Practice and Policy Interventions.

Derek M Griffith, Garima Sharma, Christopher S Holliday, Okechuku K Enyia, Matthew Valliere, Andrea R Semlow, Elizabeth C Stewart, Roger Scott Blumenthal

Abstract read
In one paragraph

Article in Preventing chronic disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 139 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Community-engaged COVID-19 contact tracing initiative in Chicago.Journal of clinical and translational science · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Derek M GriffithCenter for Research on Men's Health, Vanderbilt University, 2301 Vanderbilt Pl, PMB# 401814, Nashville, TN 37240-1814. Email: Derek.griffith@vanderbilt.edu.
Garima SharmaCiccarone Center for Prevention of Cardiovascular Disease, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Christopher S HollidayImproving Health Outcomes, American Medical Association, Chicago, Illinois.
Okechuku K EnyiaThe George Washington University Milken Institute School of Public Health, Washington, DC.
Matthew ValliereCareSouth, Baton Rouge, Louisiana.
Andrea R SemlowCenter for Research on Men's Health, Vanderbilt University, Nashville, Tennessee.
Elizabeth C StewartCenter for Research on Men's Health, Vanderbilt University, Nashville, Tennessee.
Roger Scott BlumenthalCiccarone Center for Prevention of Cardiovascular Disease, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Data suggest that more men than women are dying of coronavirus disease 2019 (COVID-19) worldwide, but it is unclear why. A biopsychosocial approach is critical for understanding the disproportionate death rate among men. Biological, psychological, behavioral, and social factors may put men at disproportionate risk of death. We propose a stepwise approach to clinical, public health, and policy interventions to reduce COVID-19-associated morbidity and mortality among men. We also review what health professionals and policy makers can do, and are doing, to address the unique COVID-19-associated needs of men.

Indexed as

BetacoronavirusHealth PolicyAngiotensin-Converting Enzyme 2Coronavirus InfectionsCOVID-19FemaleHealth PromotionHumansMalePandemicsPatient Education as TopicPeptidyl-Dipeptidase APneumonia, ViralPreventive MedicinePublic HealthRisk FactorsACE2 protein, humanAngiotensin-Converting Enzyme 2Peptidyl-Dipeptidase A

Identifiers

PMID32678061
PMCPMC7380297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.